Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Exelixis
3996
Exelixis
Technology
Biotechnology
At Exelixis, our vision is to build a global biopharmaceutical company providing new treatment options to cancer patients.
Suggest edits
Founded
1994
Follow us
Also headquartered in San Francisco
Ahelpfulghost
Twitter
Uber
Instagram
TikTok
Airbnb
Lyft
Coinbase
Fitbit
LinkedIn
Companies in the same industry
Planys Technologies
CortiCare
VeriSIM Life
JXTG Holdings
AGILEBIO
NuProbe
Ultivue
Righton
Amblyotech
Gemstone Biotherapeutics
Alexa global traffic share
Overview
Add info
Team Size
200+
Employees
I work here
Location
San Francisco
,
United States
Headquarters
Explore San Francisco
Xconomy
Roche-Exelixis Study Fails as Mixed Year Continues For Cancer Drug Combos
Health
The Motley Fool
Exelixis, Inc. Setting New Standard of Care
The Motley Fool
Exelixis, Inc. Gets Some ASCO Love
Health
The Motley Fool
Exelixis, Inc. Rides Cabometyx's Coattails to Big Gains in May
The Motley Fool
These 2 Billionaires Are Dumping Exelixis' Stock. Should You?
Stock markets
The Motley Fool
This New Data Could Push Exelixis' Cabometyx Over $1 Billion in Peak Annual Sales
The Motley Fool
Exelixis, Inc. Prepares for Blastoff
Health
Announcements
The Motley Fool
2 Big Reasons Why Shares of Exelixis, Inc. Soared 15% in April
Health
Stock markets
Earnings
The Motley Fool
Better Buy: Exelixis, Inc. vs. Roche
The Motley Fool
Exelixis, Inc.'s Cabometyx Approved: Let the Kidney Cancer Battle Begin!
Health
The Motley Fool
Exelixis, Inc.'s EKG-Like Stock Chart Hits a Low Spot
Stock markets
Health
The Motley Fool
Better Buy: Exelixis, Inc. vs. Bristol-Myers Squibb
The Motley Fool
Why Exelixis' Stock Dropped 10% on Tuesday
The Motley Fool
Exelixis, Inc. Partnering Before Approval
Health
The Motley Fool
Exelixis Inc. Stock Was Throttled in February -- Here's Why
Xconomy
On Comeback Trail, Exelixis Reels In $200M Deal For Cancer Drug
Health
Earnings
The Motley Fool
Emotional Investing Deflates Exelixis, Inc. in January
The Motley Fool
Why Exelixis, Inc. Rocketed Higher on Friday
Stock markets
Health
The Motley Fool
Exelixis, Inc. Nearly Quadrupled in 2015 -- Here's Why --
The Motley Fool
Why Exelixis, Inc. Is Trading Higher Today --
Stock markets
Health